US Bancorp’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,058
Closed -$16.3K 4212
2025
Q4
$16.3K Buy
1,058
+894
+545% +$9.85K ﹤0.01% 3156
2025
Q3
$1.63K Sell
164
-20
-11% -$208 ﹤0.01% 3781
2025
Q2
$1.82K Sell
184
-1,042
-85% -$11K ﹤0.01% 3878
2025
Q1
$15.9K Sell
1,226
-765
-38% -$10.1K ﹤0.01% 3276
2024
Q4
$25.4K Sell
1,991
-741
-27% -$8.96K ﹤0.01% 3060
2024
Q3
$30.4K Buy
2,732
+2,034
+291% +$22.4K ﹤0.01% 2963
2024
Q2
$7.84K Sell
698
-288
-29% -$3.35K ﹤0.01% 3396
2024
Q1
$12.2K Buy
986
+144
+17% +$1.88K ﹤0.01% 3264
2023
Q4
$11.8K Hold
842
﹤0.01% 3265
2023
Q3
$12.4K Sell
842
-96
-10% -$1.35K ﹤0.01% 3085
2023
Q2
$12.1K Sell
938
-2,080
-69% -$23.7K ﹤0.01% 3192
2023
Q1
$29.6K Sell
3,018
-237
-7% -$2.53K ﹤0.01% 2783
2022
Q4
$34.6K Buy
3,255
+1,907
+141% +$22.2K ﹤0.01% 2713
2022
Q3
$14K Sell
1,348
-465
-26% -$6.06K ﹤0.01% 3216
2022
Q2
$23K Hold
1,813
﹤0.01% 2969
2022
Q1
$20K Hold
1,813
﹤0.01% 3062
2021
Q4
$26K Sell
1,813
-245
-12% -$4.03K ﹤0.01% 2969
2021
Q3
$39K Hold
2,058
﹤0.01% 2762
2021
Q2
$20K Sell
2,058
-319
-13% -$2.9K ﹤0.01% 3134
2021
Q1
$24K Buy
2,377
+319
+16% +$2.63K ﹤0.01% 2936
2020
Q4
$9K Buy
2,058
+1,361
+195% +$6.16K ﹤0.01% 3209
2020
Q3
$3K Hold
697
﹤0.01% 3406
2020
Q2
$6K Buy
+697
New +$3.52K ﹤0.01% 3241
2016
Q2
Sell
-2,415
Closed -$46K 3565
2016
Q1
$46K Hold
2,415
﹤0.01% 2421
2015
Q4
$58K Buy
+2,415
New +$60.5K ﹤0.01% 2368

Other funds holding DVAX

US Bancorp's DVAX Position: Q1 2026 in Review

US Bancorp sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,058 shares — an estimated $16.3K sold.

US Bancorp first reported a position in DVAX in Q4 2015 and held it in 25 quarters. The position peaked at $58K in Q4 2015. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • US Bancorp reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • US Bancorp sold 1,058 Dynavax Technologies shares in Q1 2026, an estimated $16.3K.
  • US Bancorp first reported a position in Dynavax Technologies in Q4 2015 and held it in 25 quarters.
  • US Bancorp's Dynavax Technologies position peaked at $58K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.